AVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to AVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh
November 19, 2020 5:43 PM EST
Today's After-Hours Stock Movers:
Mesoblast Limited (Nasdaq: MESO) 27.7% HIGHER; announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis for the development, manufacture and commercialization of Mesoblasts mesenchymal stromal cell (MSC) product remestemcel-L, with an initial focus on the development of the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19.
FireEye, Inc. (NASDAQ: FEYE) 19.1% HIGHER; announced a $400 million strategic investment led by Blackstone Tactical Opportunities to... More
November 19, 2020 4:10 PM EST
AVROBIO, Inc. (NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced that it intends to offer and sell, subject to market and other conditions, $75 million of its common stock in an underwritten public offering.
The company expects to grant the underwriters a 30-day option to purchase up to $11.25 million of additional shares of its common stock (15 percent) offered in the public offering. All of the shares in the proposed offering are to be sold by the company. The offering is... More
